BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211213T150000
DTEND;TZID=Europe/Stockholm:20211213T160000
DTSTAMP:20260403T230159
CREATED:20211209T160326Z
LAST-MODIFIED:20220330T154146Z
UID:60596-1639407600-1639411200@www.scilifelab.se
SUMMARY:RNA Medicine\, the Next Frontier: Therapeutic Targeting of Non-Coding RNAs
DESCRIPTION:Anders NäärDepartment of Nutritional Sciences & Toxicology\, University of California\, Berkeley  \n\n\n\nBiography/Talk content\n\n\n\n\n\n\n\nAnders M. Näär is a Professor of Metabolic Biology in the Department of Nutritional Sciences & Toxicology at the University of California\, Berkeley. He was a postdoctoral research fellow with Robert Tjian at UC Berkeley/HHMI\, where he discovered the human Mediator transcriptional co-activator complex. Dr. Näär was a Professor in the Department of Cell Biology\, Harvard Medical School and the Massachusetts General Hospital Cancer Center. A major focus of his lab is to understand transcriptional and microRNA regulatory mechanisms controlling metabolic homeostasis to guide novel therapeutic strategies for the treatment of cardiovascular disease\, obesity\, Type 2 diabetes\, non-alcoholic fatty liver diseases (NAFLD/NASH)\, age-related macular degeneration (AMD)\, Duchenne muscular dystrophy (DMD)\, multi-drug resistant fungal infections\, and numerous types of cancer. His work resulted in a number of impactful studies\, patents and foundation of companies. In his talk\, Anders will broadcast his latest ventures in using RNA therapeutics in combating human diseases. \n\n\n\nDate: 13 December 2021Time: 3pm \n\n\n\nVenue (format hybrid): SciLifeLab\, lunchroom\, y2The ZOOM link is: https://ki-se.zoom.us/j/68353175106?pwd=bHZVYjFTMDR2YTN2ZzU1Nzk4eUZWdz09 \n\n\n\nMeeting ID: 683 5317 5106Passcode: 306128
URL:https://www.scilifelab.se/event/rna-medicine-the-next-frontier-therapeutic-targeting-of-non-coding-rnas/
LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
END:VCALENDAR